Private access

To combat the re-emergence of vaccine-preventable diseases, a joint European Joint Action on Vaccination (EU-JAV) platform, coordinated by Inserm, was launched on 4 September 2018 with 19 other European countries. The aim is to restore confidence and put in place effective measures to restore sufficient immunization coverage in all the countries involved. This action will be funded for three years with a budget of € 5.8 million, of which € 3.5 million from the European Union Health Program. Prof. Jean-Daniel Lelièvre (VRI) is at the head of WP7 - Vaccine research and development: priority-setting framework.

See the press release